BeOne Medicines (ONC) Invested Capital (2015 - 2026)
BeOne Medicines (ONC) reported Invested Capital of $5.6 billion for Q1 2026, up 31.44% year-over-year from $4.3 billion in Q1 2025, and up 7.81% on a QoQ basis from $5.2 billion in Q4 2025.
BeOne Medicines (ONC) has 12 years of Invested Capital data on file, last reported at $5.6 billion in Q1 2026.
- Quarterly Invested Capital rose 31.44% year-over-year to $5.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 billion (up 31.44% YoY) and the FY2025 annual result came in at $5.2 billion, up 54.68% from the prior year.
- Invested Capital advanced to $5.6 billion in Q1 2026 per ONC's latest filing, from $5.2 billion in the prior quarter.
- Across five years, Invested Capital topped out at $6.2 billion in Q1 2022 and bottomed at $3.4 billion in Q4 2024.
- The 5-year median for Invested Capital is $4.3 billion (2024), against an average of $4.6 billion.
- The widest annual swing landed in 2022, when Invested Capital slumped 33.18%; it then jumped 54.68% in 2025.
- Tracing ONC's Invested Capital over 5 years: stood at $4.4 billion in 2022, then retreated by 3.6% to $4.2 billion in 2023, then dropped by 20.48% to $3.4 billion in 2024, then jumped by 54.68% to $5.2 billion in 2025, then gained by 7.81% to $5.6 billion in 2026.
- Per Business Quant, the three latest ONC Invested Capital figures stand at $5.6 billion (Q1 2026), $5.2 billion (Q4 2025), and $4.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 5.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.60 Bn |
| Dec 31, 2025 | 5.20 Bn |
| Sep 30, 2025 | 4.16 Bn |
| Jun 30, 2025 | 4.58 Bn |
| Mar 31, 2025 | 4.26 Bn |
| Dec 31, 2024 | 3.36 Bn |
| Sep 30, 2024 | 4.30 Bn |
| Jun 30, 2024 | 4.22 Bn |
| Mar 31, 2024 | 4.19 Bn |
| Dec 31, 2023 | 4.23 Bn |
| Sep 30, 2023 | 4.09 Bn |
| Jun 30, 2023 | 4.22 Bn |
| Mar 31, 2023 | 4.44 Bn |
| Dec 31, 2022 | 4.38 Bn |
| Sep 30, 2022 | 5.10 Bn |
| Jun 30, 2022 | 5.58 Bn |
| Mar 31, 2022 | 6.18 Bn |
| Dec 31, 2021 | 6.56 Bn |
| Sep 30, 2021 | 3.80 Bn |
| Jun 30, 2021 | 4.04 Bn |
| Mar 31, 2021 | 4.41 Bn |
| Dec 31, 2020 | 4.20 Bn |
| Sep 30, 2020 | 4.30 Bn |
| Jun 30, 2020 | 2.57 Bn |
| Mar 31, 2020 | 2.84 Bn |
| Dec 31, 2019 | 978.36 Mn |
| Sep 30, 2019 | 1.29 Bn |
| Jun 30, 2019 | 1.58 Bn |
| Mar 31, 2019 | 1.63 Bn |
| Dec 31, 2018 | 1.79 Bn |
| Sep 30, 2018 | 2.02 Bn |
| Jun 30, 2018 | 1.24 Bn |
| Mar 31, 2018 | 1.37 Bn |
| Dec 31, 2017 | 693.45 Mn |
| Sep 30, 2017 | 759.16 Mn |
| Jun 30, 2017 | 270.17 Mn |
| Mar 31, 2017 | 310.89 Mn |
| Dec 31, 2016 | 352.91 Mn |
| Sep 30, 2016 | 187.83 Mn |
| Jun 30, 2016 | 220.05 Mn |
| Mar 31, 2016 | 243.10 Mn |
| Dec 31, 2015 | -87.17 Mn |